Brain noradrenaline takes part in the regulation of several brain func
tions. The formation of brain noradrenaline depends on brain tyrosine
(Tyr) levels, which associates with the ratio in plasma of Tyr to othe
r large, neutral amino acids (LNAA): Tyr metabolism has been studied i
n users of the new generation combined oral contraceptives (OC) and co
mparable controls at the follicular, mid-cycle, and luteal phases of t
he menstrual cycle. OC users showed significantly increased plasma Tyr
transaminase activity, and significantly decreased plasma Tyr and Tyr
/LNAA levels at mid-cycle and luteal phase, whereas plasma total 3-met
hoxy-4-hydroxyphenylglycol (MHPG) was not affected. Following an oral
protein load, the area under the curve in plasma of Tyr and Tyr/LNAA i
n OC users at the luteal phase were 43 % and 29 %, respectively, of co
ntrol levels. The results suggest that the decreased Tyr availability
to the brain in OC users may result in a substrate-limited reduction o
f brain noradrenaline formation, which, secondarily, may contribute to
disturbances of mood, coping mechanisms, and appetite in susceptible
subjects.